The medical industry has achieved a new clinical milestone. In what’s touted as a transformational shift in how we approach precision medicine, AstraZeneca released a new study, revealing how its experimental breast cancer pill delayed disease progression by over six months.
Join Dan Koh and Emaad Akhtar as they venture into the world of medicine, and analyze what AstraZeneca’s new discovery could mean for its business and cancer treatment moving forward.

Mind Your Business: How Decibelist is turning everyday objects into Art Speakers
14:53

Bigger Pic: Are stocks too optimistic as oil prices rise and risks build
12:42

Companies To Watch: L’Oréal results highlight resilient beauty demand
09:58